Skip to main content

Table 2 Fertility-sparing interventions in women with borderline ovarian tumors or ovarian cancer

From: Fertility preservation in women with cervical, endometrial or ovarian cancers

Diagnosis

Type of Surgery

Description

Reproductive and Obstetric Outcomes

Oncologic Outcome

Quality of Life

Borderline Ovarian Tumor FIGO Stage Ia

Unilateral oophorectomy/bilateral cystectomy

Removing the affected ovary only, keeping in place the unaffected one and the uterus

Spontaneous pregnancies have been reported with favorable obstetric outcome [99]

Higher recurrence rates in fertility-sparing surgery compared with radical surgery, with no difference in mortality [97, 98]. Recurrence 0 %–20 % versus 12 %–58 % when only cystectomy was performed [6]

High quality of life and higher sexual satisfaction scores after fertility-sparing surgery [103]

Borderline Ovarian Tumor FIGO Stages Ic–III

Unilateral oophorectomy/bilateral cystectomy, peritoneal staging, pelvic & para-aortic lymphadenectomy, omentectomy

Removing the affected ovary only, thorough oncological staging

Pregnancy rate of 86 %, more than half of the patients required fertility treatment [99]

No difference in recurrence or survival compared with radical surgery removing both ovaries and the uterus [6, 99].

Lack of data

Ovarian Epithelial Cancer FIGO Stage IA, grade 1

Unilateral oophorectomy, peritoneal staging, pelvic & para-aortic lymphadenectomy and omentectomy

Removing the affected ovary only, thorough oncological staging

Pregnancy rates of >60 % Pregnancies have been reported with favorable obstetric outcome [145]

5-year survival 87 %, recurrence 7–12 % [6, 17]

No difference in quality of life aspects or sexual satisfaction scores compared with radical surgery [46]

Ovarian Epithelial Cancer – FIGO Stage IA, grade 2–3 or Clear Cell Carcinoma

Unilateral oophorectomy, peritoneal staging, pelvic & para-aortic lymphadenectomy, omentectomy and adjuvant chemotherapy

Removing the affected ovary only, thorough oncological staging

Adjuvant platinum-based chemotherapy

Pregnancy rate of 80 % with live-birth rate of 65 % in women presenting with cancer grades 1–3. Higher number of women with cancer grades 1–2 attempting pregnancy in comparison with women with grade 3 cancers [87]

No difference in recurrence or survival compared with radical surgery [86]

Lack of data

Malignant Germ Cell Cancers grade I

Unilateral oophorectomy, peritoneal staging, omentectomy, pelvic & para-aortic lymphadenectomy and adjuvant chemotherapy

Removing the affected ovary only, adjuvant BEP chemotherapy has been recommended, or expectant management

76 % pregnancy rate. Pregnancies have been reported with favorable obstetric outcome [147, 148]

Fertility-sparing surgery has not been associated with impaired oncological outcome [108]

Good quality of life reported with good psychological health and sexual function [129]

  1. Modified from: Rodriguez-Wallberg KA, Oktay K. Fertility preservation during cancer treatment: clinical guidelines. Cancer management and research. 2014;6:105-17
  2. Abbreviations: FIGO International Federation of Gynecology and Obstetrics, BEP bleomycin, etoposide and cisplatin